The CSL Limited (ASX: CSL) share price has gained 14.36% over the last 6 months, despite limited news having been released by the company.
However, the period has been a busy one for CSL, as detailed in its financial year 2021 results which dropped last week.
Right now, the CSL share price is $306.91, having gained 0.26% today.
Let's take a closer look at what CSL has been up to over the past 6 months.
The 6 months just gone for CSL
The CSL share price is currently a whopping 14% higher than it was exactly 6 months ago, despite the company having been relatively quiet. Indeed, the most exciting news from CSL was also its most recent.
CSL released its full-year report to the market on Wednesday last week. Over the financial year 2021, CSL's revenue increased 9.6% and its profit after tax boosted 10% higher.
Additionally, the company increased its final dividend by 10% to US$2.22 per share.
While the CSL share price initially fell 1.4% on its FY21 results, it has gained since 4.5%.
The only other time the ASX heard price-sensitive news from CSL during the last 6 months was in May when the company announced it was to acquire the rights for etranacogene dezaparvovec (AMT-061), a late-stage haemophilia B treatment.
The deal saw CSL pay Uniqure NV US$450 million for the rights. CSL also agreed to provide milestone royalty payments to Uniqure.
Additionally, as The Motley Fool Australia recently reported, CSL's gains could have been helped along by its candidacy in potentially producing mRNA vaccines in Australia, or the Australian dollar's strength against that of the US.
CSL share price snapshot
The last 6 months have seen the CSL share price perform a strong upturn.
Right now, it is 8.3% higher than it was at the start of 2021. It is also 3.8% higher than it was this time last year.
